Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7775489 | 0.82 | HSD17B10 (0.67) | MAPTUSP2HSD17B10PLA2G2CSPHK1 | |
| SCHEMBL9637036 | 0.82 | HSD17B10 (0.67) | MAPTUSP2HSD17B10PLA2G2CSPHK1 | |
| SCHEMBL7665310 | 0.82 | HSD17B10 (0.67) | MAPTUSP2HSD17B10PLA2G2CSPHK1 | |
| SCHEMBL15070137 | 0.82 | HSD17B10 (0.67) | MAPTUSP2HSD17B10PLA2G2CSPHK1 | |
| SCHEMBL187049 | 0.82 | HSD17B10 (0.67) | MAPTUSP2HSD17B10PLA2G2CSPHK1 | |
| SCHEMBL7671997 | 0.82 | HSD17B10 (0.67) | MAPTUSP2HSD17B10PLA2G2CSPHK1 | |
| SCHEMBL706278 | 0.82 | HSD17B10 (0.67) | MAPTUSP2HSD17B10PLA2G2CSPHK1 | |
| SCHEMBL21046009 | 0.82 | HSD17B10 (0.67) | MAPTUSP2HSD17B10PLA2G2CSPHK1 | |
| SCHEMBL7661581 | 0.82 | HSD17B10 (0.67) | MAPTUSP2HSD17B10PLA2G2CSPHK1 | |
| SCHEMBL4865243 | 0.82 | HSD17B10 (0.67) | MAPTUSP2HSD17B10PLA2G2CSPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10660866-B2 | Retinol oil composition | JOHNSON & JOHNSON CONSUMER INC. (US) | 2020-05-26 | — | — | US | disclosed |
| US-20200078317-A1 | RETINOL OIL COMPOSITION | KENVUE BRANDS LLC | 2020-03-12 | — | — | US | disclosed |
| EP-3620213-A1 | RETINOL OIL COMPOSITION | JOHNSON & JOHNSON CONSUMER INC. (US) | 2020-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200078317-A1 | RETINOL OIL COMPOSITION | RBP4, RBP1, LRAT | MAPT 3473/4885LMNA 1416/4885USP2 3899/4885 |
| US-10660866-B2 | Retinol oil composition | RBP4, RBP1, LRAT | MAPT 3473/4885LMNA 1416/4885USP2 3899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.